Insulet
PODD
#1051
Rank
NZ$31.08 B
Marketcap
$443.22
Share price
-0.40%
Change (1 day)
51.29%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2023 (TTM): $2.81

According to Insulet's latest financial reports the company's current EPS (TTM) is $2.93. In 2022 the company made an earnings per share (EPS) of $0.12 a decrease over its 2021 EPS that were of $0.39.

EPS history for Insulet from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.812258.67%
2022$0.12-69.57%
2021$0.39109.09%
2020$0.19-38.89%
2019$0.31200%
2018$0.10-113.04%
2017-$0.78-9.8%
2016-$0.87-60.77%
2015-$2.2239.78%
2014-$1.5812.05%
2013-$1.41-23.15%
2012-$1.8410.2%
2011-$1.67-36.36%
2010-$2.62-36.63%
2009-$4.14-29.36%
2008-$5.86-86.74%
2007-$44.21-64.04%
2006-$122.94122.23%
2005-$55.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.44-217.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.50-287.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.67-43.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.00 718.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.06 72.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.63 58.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$9.25 215.66%๐Ÿ‡บ๐Ÿ‡ธ USA